Q4 2021 Kiniksa Pharmaceuticals Ltd Earnings Call Transcript
Thank you for standing by, and welcome to the Kiniksa Pharmaceuticals Fourth Quarter and Full Year 2021 Earnings Conference Call and Corporate Update.
(Operator Instructions)
As a reminder, today's program may be recorded. I would now like to introduce your host for today's program, Rachel Frank, Investor Relations. Please go ahead.
Thank you, operator. Good morning, everyone, and thank you for joining Kiniksa's call to discuss our fourth quarter and full year 2021 financial results and corporate update. A press release highlighting these results can be found on our website under the Investors & Media section. As for the agenda, our Chief Executive Officer, Sanj K. Patel, will start with an introduction. Ross Moat, our Chief Commercial Officer, will provide an update on our ARCALYST commercial execution. Eben Tessari, Kiniksa's Chief Operating Officer, will follow with a brief review of our recently announced strategic collaboration as well as our portfolio. Then Mark
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
